Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael J. Sweeting
Escalation Strategies for Combination Therapy Phase I Trials
Pharmaceutical Statistics
Statistics
Probability
Pharmacology
Biases Incurred From Nonrandom Repeat Testing of Haemoglobin Levels in Blood Donors: Selective Testing and Its Implications
Biometrical Journal
Medicine
Uncertainty
Statistics
Probability
Related publications
Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials
PLoS ONE
Multidisciplinary
Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/Ii Trials
Biometrics
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Immunology
Biological Sciences
Medicine
Agricultural
The Role of Age on Dose-Limiting Toxicities (DLTs) in Phase I Dose-Escalation Trials.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Designs for Phase I Trials in Ordered Groups
Statistics in Medicine
Epidemiology
Statistics
Probability
Phase I Cancer Clinical Trials
British Journal of Cancer
Cancer Research
Oncology
Progression-Free Survival Decreases With Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials
Journal of Cancer
Oncology
A Dynamic Stopping Rule for Phase I Clinical Trials
Biometrical Letters
A Phase I Dose-Escalation Study of Selumetinib in Combination With Docetaxel or Dacarbazine in Patients With Advanced Solid Tumors
BMC Cancer
Cancer Research
Oncology
Genetics
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology